Radboud University Nijmegen Medical Centre-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2023

  1. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes

    The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106

2022

  1. SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin

    Frontiers in Pharmacology, Vol. 13

2020

  1. Sarcoma treatment in the era of molecular medicine

    EMBO Molecular Medicine, Vol. 12, Núm. 11

2015

  1. Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, Núm. 24, pp. 7551-7556

2014

  1. Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: Two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts

    PLoS ONE, Vol. 9, Núm. 12

  2. The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: A meta-analysis in patients with cancer

    Pharmacogenomics Journal, Vol. 14, Núm. 2, pp. 115-119